Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neodetoxergon
- Development stage
- Unknown
- Lead developer
- Laboratori Baldacci
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Neodetoxergon is an oral dietary supplement developed and marketed by Laboratori Baldacci. It is formulated as a powder in sachets containing a combination of amino acids (L-arginine and taurine), vitamin B6 (pyridoxine), and essential mineral salts (including magnesium, potassium, and sodium). Neodetoxergon is designed to support metabolic processes, reduce tiredness and fatigue, and provide restorative and detoxifying support in individuals experiencing metabolic stress, poor dietary habits, or increased nutritional requirements.
- Brand names
- Neodetoxergon
Beyond the preview
Go deeper on Neodetoxergon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neodetoxergon.